The ESMO Tumour-Agnostic Classifier and Screener (ETAC-S): a tool for assessing tumour-agnostic potential of molecularly guided therapies and for steering drug development

Benedikt Westphalen, C.; Martins-Branco, Diogo; Rodrigues Beal, Juliana; Cardone, Claudia; Coleman, N.; M. Schram, Alison; Halabi, Susan; Michiels, Stefan; Yap, Christina; André, Fabrice; Bibeau, Frédéric; Curigliano, Giuseppe; Garralda, Elena; Kummar, Shivaani; Kurzrock, Razelle; Limaye, Sewanti; Loges, Sonja; Marabelle, Aurélien; Marchiò, Caterina; Mateo, Joaquı́n; Rodón, Jordi; Španić, Tanja; Pentheroudakis, George; Subbiah, Vivek

doi:10.1016/j.annonc.2024.07.730

Public

The ESMO Tumour-Agnostic Classifier and Screener (ETAC-S): a tool for assessing tumour-agnostic potential of molecularly guided therapies and for steering drug development

Published in Annals of Oncology • Aug 25, 2024

Authors:

C. Benedikt Westphalen

Diogo Martins-Branco

Juliana Rodrigues Beal

Abstract

BACKGROUND: Advances in precision oncology led to approval of tumour-agnostic molecularly guided treatment options (MGTOs). The minimum requirements for claiming tumour-agnostic potential remain elusive. METHODS: The European Society for Medical Oncology (ESMO) Precision Medicine Working Group (PMWG...

Subject

Medicine

Drug development

Medical physics

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!